We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Paul has over 25 years of experience in the biopharmaceutical industry, having worked in UK, European and global roles. Currently, he is consulting with biotechnology and pharmaceutical companies, helping them evaluate ‘go-to-market’ strategies and commercialisation investment decisions in Europe.
Based in Switzerland, Paul was as the International General Manager for Blueprint Medicines (a US Biotech), setting up the company from scratch in Europe, building the cross-functional team and launching the company’s first product. Prior to this, Paul lead global product strategy for some of Shire’s Rare and Genetic Diseases portfolio. Paul has launched multiple products in the UK and internationally, across multiple therapeutic areas, including speciality medicine, oncology and rare and orphan diseases.
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now